Pointel J P, Missenard V, Raffoux C, Marcelli-Barge A, Dausset J, Drouin P, Debry G
Service de Médecine G, Hôpital Jeanne-d'Arc, Toul.
J Mal Vasc. 1989;14(1):1-9.
Insulin-dependent diabetics are not equal as concerns vascular complications. Many factors have been incriminated. The object of this study was to determine if a genetic factor protected the insulin-dependent diabetic from vascular complications. The population included 31 unrelated, white insulin-dependent diabetic subjects (18 females and 13 males), with diabetes of over 20 years' duration (21 to 43 years, m +/- SD 27.82 +/- 6.03 years; age at diagnosis: 2 to 57 years, m +/- SD 22.7 +/- 15.19 years). The absence of vascular lesions was checked for by the following investigations: visual acuity, fundoscopic examination, retinal fluorescein angiography (Canon F 60 Z), systolic pressure on the thigh and ankle, Doppler velocimetry, plethysmography of the lower limbs, serum creatinine level, urinary protein. The study of the HLA A, B, DR specificities was carried out using the Tersaki microlymphocytotoxicity assay, those of C4 by high voltage gel electrophoresis followed by hemolytic detection, those of B1 using Alper's method and those of glyoxalase by gel electrophoresis followed by a glutathione redox reaction in order to test for a marker for a possible protective genetic factor against complications. The antigen frequencies found were compared with: 1) Those in the general Caucasian reference population (9th Histocompatibility Workshop, 1984). The study group presented the HLA characteristics known to occur in insulin-dependent diabetes: increase in A30, B8, B18, D6, DR3, DR4, BfF1 and decrease in A3, B7, DR2. Furthermore an increase in the frequency of DRw53, DQw2 and DQw3 alleles was noted.(ABSTRACT TRUNCATED AT 250 WORDS)
在血管并发症方面,胰岛素依赖型糖尿病患者并不相同。许多因素都被认为与此有关。本研究的目的是确定是否存在一种遗传因素能保护胰岛素依赖型糖尿病患者免受血管并发症的影响。研究人群包括31名无亲缘关系的白人胰岛素依赖型糖尿病患者(18名女性和13名男性),糖尿病病程超过20年(21至43年,平均±标准差27.82±6.03年;诊断时年龄:2至57岁,平均±标准差22.7±15.19年)。通过以下检查来确定是否存在血管病变:视力、眼底检查、视网膜荧光血管造影(佳能F 60 Z)、大腿和脚踝的收缩压、多普勒测速、下肢体积描记法、血清肌酐水平、尿蛋白。使用Tersaki微量淋巴细胞毒性试验研究HLA A、B、DR特异性,通过高压凝胶电泳随后进行溶血检测研究C4特异性,使用阿尔珀方法研究B1特异性,通过凝胶电泳随后进行谷胱甘肽氧化还原反应研究乙二醛酶特异性,以检测可能存在的针对并发症的保护性遗传因素的标志物。将所发现的抗原频率与以下数据进行比较:1)一般白种人参考人群中的数据(第9届组织相容性研讨会,1984年)。研究组呈现出胰岛素依赖型糖尿病中已知的HLA特征:A30、B8、B18、D6、DR3、DR4、BfF1频率增加,A3、B7、DR2频率降低。此外,还注意到DRw53、DQw2和DQw3等位基因频率增加。(摘要截断于250字)